22.418 articles found

ADENOSINE A2A RECEPTOR ANTAGONISTS COMBINED WITH NEUROTROPHIC ACTIVITY COMPOUNDS IN THE TREATMENT OF PARKINSON'S DISEASE

PETERS Dan c/o NeuroSearch A/S, RONN Lars Christian c/o NeuroSearch A/S, NIELSEN Karin Sandager c/o NeuroSearch A/S.

· 2002-04-04

Phenolic ester compounds that liberate hydroxytyrosol or tyrosol after their hydrolysis, their use in the treatment of neurodegenerative disease

GEERLINGS ARJAN, LOPEZ-HUERTAS LEON EDUARDO, MORALES SANCHEZ JUAN-CARLOS, BOZA PUERTA JULIO, JIMENEZ LOPEZ JESUS.

· 2002-04-03

Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394.

Lohr JB, Caligiuri MP, Edson R, Lavori P, Adler LA, Rotrosen J, Hitzemann R.

J Clin Psychopharmacol · 2002-04-01

DOI: 10.1097/00004714-200204000-00014PMID: 11910266

Force overflow and levodopa-induced dyskinesias in Parkinson's disease.

Wenzelburger R, Zhang BR, Pohle S, Klebe S, Lorenz D, Herzog J, Wilms H, Deuschl G, Krack P.

Brain · 2002-04-01

DOI: 10.1093/brain/awf084PMID: 11912119

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

Parkinson Study Group.

JAMA · 2002-04-01

DOI: 10.1001/jama.287.13.1653PMID: 11926889

Drug treatment of non-motor symptoms in Parkinson's disease.

Müller T.

Expert Opin Pharmacother · 2002-04-01

DOI: 10.1517/14656566.3.4.381PMID: 11934340

Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).

Poewe WH, Deuschl G, Gordin A, Kultalahti ER, Leinonen M, Celomen Study Group.

Acta Neurol Scand · 2002-04-01

DOI: 10.1034/j.1600-0404.2002.1o174.xPMID: 11939936

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.

Brunt ER, Brooks DJ, Korczyn AD, Montastruc JL, Stocchi F, 043 Study Group.

J Neural Transm (Vienna) · 2002-04-01

DOI: 10.1007/s007020200040PMID: 11956968

[Stereotactic surgery for treatment of Parkinson's disease].

Katayama Y.

No Shinkei Geka · 2002-04-01

PMID: 11968823

New treatment improves symptoms of Parkinson's disease.

Mayor S.

BMJ · 2002-04-01

DOI: 10.1136/bmj.324.7344.997PMID: 11976237

Measuring the impact of Parkinson's disease: an occupational therapy perspective.

Gaudet P.

Can J Occup Ther · 2002-04-01

DOI: 10.1177/000841740206900206PMID: 11977869

Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.

Coulson BS, Fenner SG, Almeida OP.

Aust N Z J Psychiatry · 2002-04-01

DOI: 10.1046/j.1440-1614.2002.00977.xPMID: 11982550